Article
Bio-engineering a common probiotic to exploit colonic inflammation promotes reliable efficacy in translational models of colitis
2024-10-09
Abstract excerpt
The intricate balance between the gut microbiome and host health inspires innovations in drug development. Commensal bacteria provide a multi-targeted approach ideal for treating complex medical conditions, like inflammatory bowel disease (IBD). These bacteria are self-replicating factories with broad targets that promote balanced intestinal inflammation, mucosal barrier function, and eubiosis. Yet, the lack of su...
Topics
Open a Topic to create a Post that cites this publication.
- Clostridium difficile and Clostridium perfringens research
- Enterobacteriaceae and Cronobacter Research
- Escherichia coli research studies
- Gastrointestinal motility and disorders
- Gut microbiota and health
- Pharmacological Effects of Natural Compounds
- Probiotics and Fermented Foods
- Viral gastroenteritis research and epidemiology
Identifiers and source
- Literature Corpus work
- 7216559c-a83f-5910-a7e4-31c268a8f14f
- DOI
- 10.1101/2024.10.08.617317
